What is the KYMR stock price prediction for next 2 weeks?

According to our price prediction algorithm,Kymera Therapeutics, Inc. (KYMR) price will be around $78.69 in the next 2 weeks. This means it will decrease by -6.958264365098134 from the last closing price. This prediction may vary from other time period filters for KYMR stock.

What can be the highest Possible price of KYMR stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, KYMR can achieve the highest price of $81.36 which is -3.8074311299083106 lower than last closing price. This prediction may vary from other time period filters for KYMR stock.

What can be the lowest Possible price of KYMR stock in next 2 weeks?

As per the forecast and algorithmic analysis, KYMR stock price can be as low as $75.93 which is -10.230485029552712 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for KYMR stock.

Will KYMR stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that KYMR stock will lose-6.958264365098134 in the next 2 weeks. This prediction may vary from other time period filters for KYMR stock.

What is KYMR stock last closing price?

Last closing price of KYMR stock was $81.52.

What is KYMR stock price prediction?

KYMR stock price prediction means predicting the future closing prices of KYMR stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of KYMR stock in a certain time period.

How we predict KYMR stock future prices?

If you are searching for KYMR stock forecast, analysis or price prediction, then you might be wondering what Kymera Therapeutics, Inc. (KYMR) will do in the future. Our KYMR price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This KYMR price prediction will likely answer most of your questions.

How frequent we update KYMR stock predictions?

We are updating the forecasts for the KYMR stock on daily basis.

Is using ML forecasting for KYMR stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for KYMR stock same for all the time periods?

No, the prediction for KYMR stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Kymera Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$81.52-10.1%Since 2 Weeks

Predicted Price$78.69-6.96%For 2 Weeks

Upper Predicted Price$81.36-3.81%For 2 Weeks

Lower Predicted Price$75.93-10.23%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of KYMR will decline by -6.96% over the next 2 Weeks and hit $78.69 by Tuesday, March 24, 2026. In that time frame, KYMR's share price is expected to range between $75.93 and $81.36.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 24, 2026	75.93	78.69	81.36
Mar 23, 2026	76.69	79.33	81.79
Mar 20, 2026	78.25	80.59	82.88
Mar 19, 2026	80.68	82.78	84.80
Mar 18, 2026	79.66	81.64	83.43
Mar 17, 2026	79.67	81.59	83.41
Mar 16, 2026	80.38	82.23	83.95
Mar 13, 2026	81.62	83.49	85.15
Mar 12, 2026	84.01	85.67	87.28
Mar 11, 2026	82.82	84.54	86.27

KYMR shares fell -3.62% in Wednesday, March 11, 2026's trading session, dropping from a previous close of $84.58 to move at $81.52. The stock demonstrated notable intraday movement (see KYMR's key stats for a full breakdown), fluctuating between $81.44 and $84.56, a +3.83% trading range. While recent weeks have seen some volatility, KYMR has managed to secure a -10.43% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 688.87K shares changing hands, 87.34K more than the previous session. This amounted to $56.16M in total market activity.

Will KYMR Continue Its Downward Trend?

According to analyst ratings and projections for KYMR, Kymera Therapeutics, Inc. shares are anticipated to decrease by -0.20%, potentially reaching $81.36 per share by March 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for KYMR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the KYMR stock forecast, now is not the best time to buy KYMR stock because its current trading price is +3.59% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KYMR covering social and institutional perspectives.

KYMR Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into KYMR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.65% to 49.11%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 54.20%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.38%, maintains a neutral outlook for the long term. Insights into KYMR's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Kymera Therapeutics Short-Term Forecasts

KYMR Forecast For Next 5 Days

Our algorithm anticipates Kymera Therapeutics (KYMR) stock could hit $83.03 by Mar 18, 2026. This represents a +1.86% fall from today's price, following a -6.77% change over the past five days.

KYMR Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Kymera Therapeutics, Inc. (KYMR) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $84.22, which would mean a +3.31% increase from the current price of $81.52. Projections for this period range from a high of $98.31 to a low of $69.68.

KYMR Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Kymera Therapeutics's price over the next three months point to a rise. KYMR stock is expected to peak at $94.04 on May 12, 2026 after potentially dipping to $77.21 on Mar 20, 2026. On average, KYMR is likely to trade around $85.50 in the coming 90 days.

Kymera Therapeutics Stock Forecast 2025

Based on our predictive models, Kymera Therapeutics (KYMR) is expected to trade between $77.21 and $105.75 throughout 2026. This would result in an average price of $88.83, potentially offering investors a +8.97% return from current levels.

Kymera Therapeutics, Inc. Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, Kymera Therapeutics, Inc. (KYMR) is positioned to show a strong performance in March 2026. The price is predicted to move between $77.21 and $88.18, settling at an average of $82.50. This could translate to a +1.20% gain.

April 2026

Based on current market signals, Kymera Therapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $79.03 to $90.49, with a likely average price of $85.05. Investors could expect a potential return of +4.33%.

May 2026

Our predictive algorithms indicate Kymera Therapeutics, Inc. stock may see a shift in May 2026. The expected range spans $81.54–$94.04, with an average target of $87.81. This represents a positive outlook and a possible gain of +7.72%.

June 2026

Analyzing established trends, Kymera Therapeutics, Inc. looks set to move in June 2026. Projections place the stock between $80.02 and $91.32, averaging around $85.56. This suggests a +4.96% gain from current levels.

July 2026

Market indicators suggest Kymera Therapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $80.74 to $95.39, with a midpoint forecast of $87.90. The stock might deliver a +7.83% gain.

August 2026

Forecasting for August 2026, models estimate that Kymera Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $82.36 and $94.36, averaging $88.26. This signals a positive trajectory with potential returns around +8.27%.

September 2026

According to our latest forecast models, Kymera Therapeutics, Inc. (KYMR) is positioned to show a strong performance in September 2026. The price is predicted to move between $84.61 and $96.15, settling at an average of $90.69. This could translate to a +11.25% gain.

October 2026

Based on current market signals, Kymera Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $86.09 to $99.89, with a likely average price of $93.00. Investors could expect a potential return of +14.08%.

November 2026

Our predictive algorithms indicate Kymera Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $85.44–$105.75, with an average target of $91.42. This represents a positive outlook and a possible gain of +12.14%.

December 2026

Analyzing established trends, Kymera Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $86.51 and $101.29, averaging around $93.66. This suggests a +14.89% gain from current levels.

January 2027

Market indicators suggest Kymera Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $87.30 to $99.66, with a midpoint forecast of $93.69. The stock might deliver a +14.93% gain.

February 2027

Forecasting for February 2027, models estimate that Kymera Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $90.76 and $101.45, averaging $96.21. This signals a positive trajectory with potential returns around +18.02%.

March 2027

According to our latest forecast models, Kymera Therapeutics, Inc. (KYMR) is positioned to show a strong performance in March 2027. The price is predicted to move between $93.79 and $104.39, settling at an average of $99.69. This could translate to a +22.29% gain.

KYMR's history of dividends and stock splits also plays a role in long-term investor confidence.